Lessons learned from the pandemic for the pharmaceutical supply chain
We focus on how Covid-19 has highlighted the need for resilient and flexible pharmaceutical supply chains and the…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
16 Feb 22
We focus on how Covid-19 has highlighted the need for resilient and flexible pharmaceutical supply chains and the…
16 Feb 22
ImmunoGen will receive $13m in upfront payment for initial targets and is eligible to receive an additional $32.5m…
16 Feb 22
The company will establish new subsidiaries in Malaysia, Taiwan, Singapore, and Hong Kong, to scale up its mRNA…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
15 Feb 22
The agreement follows the US government’s initial deal for 700,000 doses of Evusheld, which are already being administered…
14 Feb 22
We focus on how adaptive trial designs have enabled clinical research, which could lower overall drug development costs…
14 Feb 22
According to pseudovirus and authentic virus data, bebtelovimab has shown neutralisation activity against widely circulating variant of concern,…
11 Feb 22
The US drugmaker has used several insights from the CytoReason’ platform, in several of its R&D programmes across…
11 Feb 22
The investigational Covid-19 drug, bebtelovimab, has shown to maintain binding and neutralising activity across currently known and reported…
10 Feb 22
We focus on the importance of collaboration, outsourcing relationships and avoiding bottlenecks to find out what makes a…
10 Feb 22
The investment round, jointly led by SoftBank Vision Fund 2 and RA Capital Management, will advance the company’s…